PREVIOUS
✖
Organ-on-Chip Technology
September 23 , 2024
61 days
185
0
- The Government of India announced the ‘BioE3’ policy to drive innovation in the biotechnology sector.
- For this, it has established biomanufacturing facilities, bio-AI hubs, and bio-foundries.
- The policy also aims to boost the development of biologics such as gene therapy and cell therapy.
- The global organ-on-chip market is expected to be worth around $1.4 billion by 2032.
- An organ-on-chip is a small device designed to recreate the dynamic functions of some human organ in a controlled microenvironment.
- They are expected to be better than the cell cultures and animal models, that researchers currently use at testing the effects of a drug.
- India amended the New Drugs and Clinical Trials Rules 2019 to permit the use of human organs-on-chips.
Leave a Reply
Your Comment is awaiting moderation.